Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models
Article 2017 en
Authors
CB
Cristina Belgiovine
EB
Ezia Bello
ML
Manuela Liguori
Abstract
1 min read
The results illustrate that lurbinectedin affects at multiple levels the inflammatory microenvironment by acting on the viability and functional activity of mononuclear phagocytes. These peculiar effects, combined with its intrinsic activity against cancer cells, make lurbinectedin a compound of particular interest in oncology.
Antonio Sica, Alessandra Saccani, Barbara Bottazzi, Sergio Bernasconi, Paola Allavena, Brancatelli Gaetano, Francesca Fei, Graig LaRosa, Chris J. Scotton, Frances R. Balkwill, Alberto Mantovani
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.